Analysts have maintained their price target for Elixirr International at £11.30, reflecting only minor adjustments in key assumptions. This is due to a steady financial outlook and marginal improvements in profit margin and discount rate.
What's in the News
- Elixirr International plc (LSE:ELIX) has been added to the S&P Global BMI Index (Key Developments)
- The company has also joined the FTSE All-Share Index (GBP) (Key Developments)
Valuation Changes
- Consensus Analyst Price Target remains unchanged at £11.30.
- The discount rate has decreased slightly from 7.13% to 7.09%.
- The revenue growth forecast has decreased marginally from 18.62% to 18.42%.
- The net profit margin has risen slightly from 19.78% to 19.88%.
- The future P/E ratio has decreased marginally from 15.25x to 15.23x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.